Alzheimer's drug from Eli Lilly wins backing of FDA committee - The Washington Post
- Alzheimer's drug from Eli Lilly wins backing of FDA committee The Washington Post
- FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment Yahoo Finance
- Alzheimer's drug donanemab gets FDA advisory committee's green light : Shots - Health News NPR
- Opinion | An Alzheimer's Advance, Not a Cure-All The Wall Street Journal
- Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's Drug The New York Times